Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Glia. 2015 Sep 4;64(1):105–121. doi: 10.1002/glia.22906

Fig. 3. Loss of Gal-3 prevented TMEV-induced chemokine increases in the SVZ.

Fig. 3

(A–D) Concentrations of CXCL10, CCL8, CCL5 and CCL2 in the SVZ measured by ELISA in shams and 7 dpi in WT and Gal-3−/− C57BL/6 and SJL/J mice (I–L). (E–H) Concentrations of CXCL10, CCL8, CCL5 and CCL2 in the cerebral cortex measured by ELISA in shams and 7 dpi in WT and Gal-3−/− C57BL/6 and SJL/J mice (M–P). *P<0.05 Gal-3−/− compared to WT, ** P<0.01, ***P<0.001, $ P<0.05 TMEV treated compared to shams, $$ P<0.01.